PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Type-2 immune responses are well-established drivers of chronic inflammatory diseases, such as asthma, and represent a large burden on public health systems. The transcription factor PPARγ is known to promote M2-macrophage and alveolar macrophage development. Here, we report that PPARγ plays a key role in both T cells and dendritic cells (DCs) for development of type-2 immune responses. It is predominantly expressed in mouse Th2 cells in vitro and in vivo as well as human Th2 cells from allergic patients. Using conditional knockouts, we show that PPARγ signaling in T cells, although largely dispensable for IL-4 induction, is critical for IL-33–driven Th2 effector function in type-2 allergic airway responses. Furthermore, we demonstrate that IL-4 and IL-33 promote up-regulation of PPARγ in lung-resident CD11b+ DCs, which enhances migration to draining lymph nodes and Th2 priming capacity. Thus, we uncover a surprising proinflammatory role for PPARγ and establish it as a novel, important mediator of DC–T cell interactions in type-2 immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 2×
“CD4 effector memory T cell subsets were FACS-sorted (FAC SAria III; BD) as follows and after gating on CD4CD8CD14CD19CD25CD56CD45RA CCR7 cells: CRTh2CCR4CXCR3CCR6 (enriched in inflammatory Th2 cells); CCR4CRTh2CXCR3CCR6 (enriched in Th2 cells); CXCR3CCR4CCR6 (enriched in Th1 cells); CXCR3CCR6CCR4 (enriched in Th1* cel…”
Self-citationThe microbiota regulates type 2 immunity through RORγt + T cells
Ohnmacht, C., Park, J.-H., Cording, S., Wing, J. B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., et al. (2015) · Science · doi:10.1126/science.aac4263 · Cited by 863 · cited 1×
“Treg cells were recently described to consist of distinct subsets that can be distinguished by expression of the transcription factors ROR γ t and GATA3 (Wohlfert et al., 2011; Ohnmacht et al., 2015).”
The development and function of lung-resident macrophages and dendritic cells
Kopf, M., Schneider, C., & Nobs, S. P. (2015) · Nature Immunology · doi:10.1038/ni.3052 · Cited by 555
Self-citationHolt, P. G., Oliver, J., Bilyk, N., McMenamin, C., McMenamin, P. G., Kraal, G., & Thepen, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.397 · Cited by 531 · cited 1×
“These data confirm previous studies showing that AMs interfere with T cell activation and, therefore, suppress lung inflammation (Thepen et al., 1989; Holt et al., 1993; Soroosh et al., 2013).”
Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance
Soroosh, P., Doherty, T. A., Duan, W., Mehta, A. K., Choi, H., Adams, Y. F., Mikulski, Z., Khorram, N., Rosenthal, P., Broide, D. H., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121849 · Cited by 340 · cited 1×
“These data confirm previous studies showing that AMs interfere with T cell activation and, therefore, suppress lung inflammation (Thepen et al., 1989; Holt et al., 1993; Soroosh et al., 2013).”
ResultNovel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68 · cited 2×
“dIscussIon Dysregulated type-2 immune responses are responsible for some of the most-common, chronic inflammatory diseases, and to date, no therapies with high specificity and efficacy are available for treatment of conditions, such as asthma (Tan et al., 2016).”
Cited by
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Dendritic cell subsets in T cell programming: location dictates function
Eisenbarth, S. C. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0088-1 · Cited by 827
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154338 · Cited by 720
PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
Hernandez-Quiles, M., Broekema, M. F., & Kalkhoven, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.624112 · Cited by 433
Tibbitt, C. A., Stark, J. M., Martens, L., Ma, J., Mold, J. E., Deswarte, K., Oliynyk, G., Feng, X., Lambrecht, B. N., De Bleser, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.014 · Cited by 260
Metadata
- Authors
- Nobs, S. P., Natali, S., Pohlmeier, L., Okreglicka, K., Schneider, C., Kurrer, M., Sallusto, F., & Kopf, M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-08-10
- Volume
- 214
- Issue
- 10
- Pages
- 3015-3035
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2742795003
- Cited by
- 154
- References
- 6
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. https://app.cochat.ai/papers/10.1084/jem.20162069
- The paper
- Nobs, S. P., Natali, S., Pohlmeier, L., Okreglicka, K., Schneider, C., Kurrer, M., Sallusto, F., & Kopf, M. (2017). PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20162069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.